Highbridge Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Hold |
0
| – | – | – | 92 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 93 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 75 |
|
|
2018
Q1 | – | Sell |
-50,266
| Closed | -$3.42M | – | 1200 |
|
|
2017
Q4 | $3.42M | Buy |
50,266
+266
| +0.5% | +$18.1K | 0.06% | 262 |
|
|
2017
Q3 | $4.12M | Buy |
50,000
+39,200
| +363% | +$3.23M | 0.06% | 267 |
|
|
2017
Q2 | $1.01M | Sell |
10,800
-1,069
| -9% | -$100K | 0.02% | 456 |
|
|
2017
Q1 | $755K | Buy |
11,869
+1,869
| +19% | +$119K | 0.01% | 599 |
|
|
2016
Q4 | $444K | Sell |
10,000
-2,015
| -17% | -$89.5K | 0.01% | 678 |
|
|
2016
Q3 | $433K | Buy |
+12,015
| New | +$433K | 0.01% | 717 |
|
|
2016
Q2 | – | Sell |
-11,057
| Closed | -$212K | – | 1368 |
|
|
2016
Q1 | $212K | Buy |
+11,057
| New | +$212K | ﹤0.01% | 710 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1187 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1141 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1076 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 1053 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 969 |
|